Maybe I can jump in quickly, if it works.
One thing we're doing right now is actually moving regulations. We've just gone to Canada Gazette, part I, to ask companies or people to basically bring forward submissions of disaggregated data. Whatever data they have that they may have provided to other jurisdictions, we want them to provide to us.
That's one step. Again, it's gone to CG, part I. I think stakeholders were quite happy with it. We're hoping to move that forward within the next year or so to finalize it .
A second step we're taking is part of our clinical trials reform. We're looking at the whole regulatory structure of clinical trials. One thing we want to ask companies to do is to provide us with a diversity plan. We've gone out and my colleagues have consulted on it. Right now, it seems to have been received favourably, so that would again require providers to try to provide us with disaggregated data.
Those would be—